Position in AZN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$33,612,597
New position
Shares Held
170,432
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 82.62122136687947.ToString("F0")%
Shared 0.18189072474652646.ToString("F0")%
None 17.196887908374016.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $479,605,626 across 16 Drug Manufacturers - General names. AZN ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
115,489 | $106,223,316 | |
| 2 | JNJ |
Johnson & Johnson
|
391,963 | $95,811,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
480,635 | $57,815,583 | |
| 4 | ABBV |
AbbVie Inc.
|
247,510 | $53,830,948 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
170,432 | $33,612,597 | |
| 6 | AMGN |
Amgen Inc
|
92,288 | $32,471,531 | |
| 7 | NVS |
Novartis AG
|
136,897 | $20,911,015 | |
| 8 | PFE |
Pfizer Inc
|
635,026 | $17,831,528 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,612,597 | 170,432 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||